Stringent regulatory processes designed to protect the public from inappropriately tested treatments often overlook the crucial role of the doctor.
Regulatory bodies are expected to protect the public from the of inappropriately tested treatments—a shield against vested interest of drug and device companies to sell products of their safety and effectiveness. The idea of the industrialist focused on short term advantage and lives with low quality components used to save costs is familiar to the public and seems to justify regulatory processes. But one person is forgotten in equation—the doctor.
Mario et al. (Sat,) reported a editorial. Stringent regulatory processes designed to protect the public from inappropriately tested treatments often overlook the crucial role of the doctor.